Latanoprost for the prevention of ocular hypertension after neodymium:yttrium-aluminum- garnet laser posterior capsulotomy

Aim: To evaluate the efficacy of latanoprost for the prevention of ocular hypertension after neodymium: yttrium-aluminum-garnet laser posterior capsulotomy. Methods: Fifty six eyes of 56 consecutive patients receiving neodymium:yttrium-aluminum-garnet laser capsulotomy for posterior capsule opacification were randomized to group 1, who received 1 drop of latanoprost 0.005%, or to group 2, who received 1 drop of normal saline, 1 hour before the laser treatment. Intraocular pressures were taken before instillation of the eye drop, and at 1 hour and 2 hours after the laser procedure. Student’s t-test was used to analyze the differences in intraocular pressures between the 2 groups. Results: There were no statistically significant changes in the mean intraocular pressures of the 2 groups at 1 and 2 hours after neodymium:yttrium-aluminum-garnet laser capsulotomy compared with the baseline. There was